2013, Number 606
<< Back Next >>
Rev Med Cos Cen 2013; 70 (606)
Virus del papiloma humano
Alfaro CA, Fournier PM
Language: Spanish
References: 17
Page: 211-217
PDF size: 177.87 Kb.
ABSTRACT
The Human Papillomavirus
(HPV) is the sexually transmitted
disease most common in the
world, that mainly affects
women and men in their late
teens and early age of twenty;
which is a public health
problem, often related to lack of
efficient health systems and the
prevention and early uptake for
early diagnosis, which is closely
linked with cervical cancer. It
describes that there are two
groups of infection: low-risk
types that often cause genital
warts or subclinical infection,
and high-risk HPV types 16
and 18 common progressing to
cervical cancer. As is known, the
immune system is responsible
for clarifying or clean most HPV
infections, but in some cases can
not get rid of it, this is where the
most important is prevention by
vaccination and early diagnosis
REFERENCES
Bernstein S.J, MD, Sanchez-Ramos L, MD, and Ndubisi B, MD, [et al]. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol. 2001; Volume 185, Number 2, 185:308-17.
Doerfler D, Bernhaus A, Kottmel A, [et al]. Human papilloma virus infection prior to coitarche. Am J Obstet Gynecol. 2009; 200:487.e1-487.e5.
Gonzalez Merlo, J Gonzalez Bosquet, E Ginecología, Barcelona. Ed. Masson. 3ra edición 2003.pag 226-231.
Haug C.J, M.D., Ph.D. Human Papillomavirus Vaccination — Reasons for Caution. N Engl J Med. 2008; 359-8.
Heideman D, Snijders P, Berkhof J, [et al]. Vaccination against HPV: indications for women and the impact on the cervical screening programme. BJOG 2008; 115:938–946.
Jon K. Hathaway, MD, PhD. Indiana. HPV: Diagnosis, Prevention, and Treatment. Clinical Obstetrics and Gynecology. 2012, Volume 55, Number 3, 671–680.
Kitchener H.C. Genital virus infection and cervical neoplasia. British Journal of Obstetrics and Gynaecology. February 1988, Vol. 95, pp. 182-191.
Michala L, Argyri E, Tsimplaki E, [et al]. Human Papilloma Virus infection in sexually active adolescent girls. Gynecologic Oncology 126; 2012, 207–210.
Muñoz N, M.D., Bosch F.X, M.D., de Sanjose S, M.D., [et al]. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med 2003; 348:518-27.
Naucler P, M.D., Ph.D., Ryd W, M.D., Törnberg S, M.D., Ph.D., [et al]. Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer. N Engl J Med, 2007; 357:1589-97.
Oaknin A., Díaz de Corcuera I., Rodríguez-Freixinós V., [et al]. SEOM guidelines for cervical cancer. Clin Transl Oncol, 2012; 14:516-519.
Padilla-Paz L.A, MD. Human Papillomavirus Vaccine: History, Immunology, Current Status, and Future Prospects. Clinical Obstetrics and Gynecology. 2005; Volume 48, Number 1, 226–240.
Roland KB, Soman A, Bernard VB, [et al]. Human papillomavirus and Papanicolaou test screening interval recommendations in the United States. Am J Obstet Gynecol. 2011; 205:447.e18.
Rosa MI, Fachel JMG, Rosa DD, [et al]. Persistence and clearance of human papillomavirus infection: a prospective cohort study. Am J Obstet Gyneco.l 2008; 199:617.e1-617.e7.
Schorge, John [et al] Williams Ginecologia, Mexico. Ed. Mc Graw Hill. 1 ed 2009, pag 617-642, 646-653.
Winer R.L, Ph.D., Hughes J.P, Ph.D., Feng Q, Ph.D., [et al]. Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women. N Engl J Med 2006; 354:2645-54.
Wright TC, Stoler MH, Behrens CM, [et al]. The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 2012; 206:46.e1-11.
Full text